News Coverage from
Amerian Society of Hematology
American Diabetes Association

The Endocrine Society

American Society of Clinical Oncology

American College of Physicians

American College of Obstetricians and Gynecologists

American Academy of Neurology

American College of Cardiology

American Academy of Allergy, Asthma and Immunology

Amerian Society of Hematology

American Heart Association

American College of Chest Physicians

American Academy of Ophthalmology

American Academy of Pediatrics

American College of Rheumatology

American Academy of Family Physicians

Interscience Conference on Antimicrobial Agents and Chemotherapy

The Endocrine Society

American Diabetes Association

American Society of Clinical Oncology

American Academy of Neurology

American College of Physicians

American Urological Association

American College of Cardiology

American Academy of Allergy Asthma & Immunology

American Society of Hematology

American Heart Association

American Academy of Ophthalmology

American College of Chest Physicians

American College of Rheumatology

Interscience Conference on Antimicrobial Agents & Chemotherapy

American College of Surgeons

American Academy of Pediatrics

American Academy of Family Physicians

American Diabetes Association

American Society of Clinical Oncology

American Urological Association

American College of Physicians

American College of Cardiology

American Academy of Allergy Asthma and Immunology

American Academy of Orthopaedic Surgeons

Meeting Dates:  December 5th through December 8th, 2009
Last Update:
Thursday, December 10, 2009
Location:  New Orleans, LA
Click here to view this story as a Adobe PDF Click here to lower the font size Click here to raise the font size Click here to print this page Click here to E-mail this story to a friend

Background ITP Varies in Incidence Between Age, Gender in Pediatric and Adult Populations, Study Shows

   Research shows an interaction between age and sex with the incidence of background immune thrombocytopenia (ITP), suggesting that patterns of disease burden differ among children, teenagers, and the adult population. The data were presented at the 51st Annual Meeting and Exposition of the American Society of Hematology in New Orleans.
   Background immune thrombocytopenia is an autoimmune condition characterized by low blood platelet counts. It has been reported that the epidemiology of ITP in the pediatric population (<18 years) is different from that in adults. In this new study, British and American researchers assessed the incidence of ITP in the pediatric population as compared with the adult population in a large UK-based primary care database –- the General Practice Research Database (GPRD). 
   The researchers identified all patients with a first-time diagnosis of ITP recorded in the GPRD during the period 1990-2005. Age- and sex-specific incidences were estimated as the number of patients with a first-time recorded diagnosis of ITP divided by the person-time contributed by all subjects in the database who did not have a diagnosis of ITP. 
   Of the total of 1146 incident cases of ITP among 29.2 million person-years (PY) of observation during the study period, the researchers noted 257 incident cases of pediatric ITP (<18 years) in 6.1 million PY, of whom 197 were children (<10 years) and 60 were teenagers (10 – 17 years) at diagnosis. The age-specific incidence estimate for ITP in children was 5.7 per 100,000 PY (95% confidence interval [CI], 5.0 to 6.6 per 100,000 PY), with a statistically significantly 60% higher incidence in boys compared to girls. By contrast, among teenagers the overall incidence was 2.2 (95% CI, 1.7 to 2.9) per 100,000 PY with a suggestion of a 50% higher incidence rate in girls compared to boys. The overall incidence in the adult population was 3.8 (95% CI, 3.6 – 4.1) per 100,000 PY, with women having a statistically significantly 48% higher incidence compared to men.
   As noted, the results showed an interaction between age and sex with ITP incidence. Further investigation into these differences, including comorbidities and treatment practices is warranted.